Latest news
Arrowhead Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocusGuruFocus · Thu, 06 Aug 2026 23:37:58 GMTArrowhead Pharmaceuticals, Inc. (ARWR) Stock Forecasts - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 22:07:42 GMTARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:38:00 GMTArrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $110.2, Implies 23% Upside - TradingViewTradingView · Wed, 05 Aug 2026 09:20:04 GMTArrowhead Pharmaceuticals Inc (ARWR) (Q3 2026) Earnings Call Highlights: Strong Phase III Data ... - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 05:05:00 GMTArrowhead Pharmaceuticals Inc (ARWR) (Q3 2026) Earnings Call Hig - GuruFocusGuruFocus · Wed, 05 Aug 2026 05:04:57 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - BioSpaceBioSpace · Wed, 05 Aug 2026 02:46:50 GMTArrowhead Pharmaceuticals (NASDAQ:ARWR) Announces Quarterly Earnings Results - MarketBeatMarketBeat · Wed, 05 Aug 2026 00:14:20 GMT